Your partner in precision diagnostics.
Location: Germany, Bavaria, Regensburg
Employees: 11-50
Phone: +49 941 28094900
Total raised: $21.24M
Founded date: 2004
Investors 1
| Date | Name | Website |
| - | SHS Gesell... | shs-capita... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.12.2022 | - | $21.24M | - |
Mentions in press and media 13
| Date | Title | Description |
| 01.08.2023 | FDA Clears Numares Health Cardiovascular Diagnostic Test and Core Technology Platform | THE WOODLANDS, Texas and REGENSBURG, Germany, Aug. 1, 2023 /PRNewswire/ -- The US Food and Drug Administration has cleared a Numares Health test, the AXINON® LDL-p Test System, as a new tool physicians can use to measure lipoproteins for pa... |
| 25.07.2023 | Numares Health: FDA clears cardiovascular diagnostic test and core technology platform | The US Food and Drug Administration has cleared a Numares Health test, the AXINON® LDL-p Test System, as a new tool physicians can use to measure lipoproteins for patients at risk for cardiovascular disease. Currently, Numares is the only c... |
| 21.12.2022 | Numares Health Receives Up To €20M from European Investment Bank | Numares Health AG, a Regensburg, Germany-based provider of a fully automated in-vitro diagnostics platform, received up to €40m in funding. The European Investment Bank provided un up to €20m quasi equity financing for further research and ... |
| 03.11.2022 | Numares Health & Mayo Clinic Expands AI-Enabled Diagnostic Testing Collaboration | Numares AXINON® System What You Should Know: Numares is a German healthcare diagnostics company that develops advanced tests to aid in diagnosis and measurement of disease progression by applying machine learning to metabolomics and other b... |
| 11.07.2022 | Numares Health and Mayo Clinic Strengthening Collaboration for Improved Diagnostic Tests | Numares Health, based in Regensburg with U.S. headquarters in the Woodlands, Texas and U.S. based Mayo Clinic expanded their collaboration to develop AI- enabled diagnostic testing that is more accurate and reliable than current U.S. tests ... |
| 15.12.2021 | numares Appoints Dr. Gregory Heath As New Member of the Supervisory Board and Submits an Additional Test to the FDA | BOSTON & REGENSBURG, Germany–(BUSINESS WIRE)–December 15, 2021– Leading NMR diagnostics company numares AG appoints Dr. Gregory Heath as new member of the Supervisory Board. Dr. Heath has a long career in the diagnostics and life scienc... |
| 28.10.2021 | numares and Oxford University sign exclusive license agreement for novel multi-marker diagnostics in multiple sclerosis | REGENSBURG, Germany, and OXFORD, England–(BUSINESS WIRE)–October 28, 2021– Leading NMR diagnostics company numares AG today announced that the company signed an exclusive licence agreement with Oxford University Innovation. This allows numa... |
| 24.03.2021 | numares announces FDA 510(k) Submission of AXINON System®, a NMR platform for metabolomics-based, AI-driven Diagnostics | BOSTON, & REGENSBURG, Germany–(BUSINESS WIRE)–March 24, 2021– Leading NMR diagnostics company numares AG today announced that the company made a 510(k) submission to the U.S. Food and Drug Administration (FDA) for its AXINON® IVD System... |
| 25.02.2021 | numares’ Novel GFR Equation Allows Accurate Assessment of Renal Insufficiency in Proof of Concept | BOSTON, Mass. & REGENSBURG, Germany–(BUSINESS WIRE)–February 25, 2021– Leading NMR diagnostics company numares recently published data showing that its novel, multi-marker approach to assess kidney function allowed for a more precise es... |
| 21.01.2021 | numares and Bruker Sign Agreement to Enable Advanced Metabolomics-based Clinical Diagnostics | BOSTON, United States & REGENSBURG, Germany–(BUSINESS WIRE)–January 21, 2021– Leading metabolomics based diagnostics company numares AG and analytical instrumentation and solution provider Bruker Corporation have signed an agreement to ... |
Show more